Neuroprotective Activity of Sesbania grandifolara Seeds Extract against Celecoxib induced Amnesia in Mice

Semwal, Verma, Murti, and Yadav: Neuroprotective Activity of Sesbania grandifolara Seeds Extract against Celecoxib induced Amnesia in Mice

Authors

INTRODUCTION

Alzheimer’s disease (AD) is one of the most common form of dementia in which the neural injury is primarily in the hippocampus and cortex1 characterized by memory loss, language deterioration, poor judgment, impaired visuospatial skills etc.2 According to World Health Organization report 44 million of people are suffering from dementia worldwide, estimated that by the year 2050, 135 million of people will have dementia.3,4 The treatment of mild moderate stage of AD is only symptomatic5 however these authorized medications have disadvantages including extreme peripheral and central side effects, including git disturbance, insomnia, anxiety and depression.6 The unwanted side effects caused by authorized medications used to treat AD have constrained researcher to research more secure AChE inhibitors from natural sources. Natural products always have been used as a primary source of medicine from ancient time for the treatment of disease and injury. Still today in many developing country of World, huge number of population using medicinal plants for the treatment of neurodegenerative disorder.79

Sesbania grandiflora (SG) is a fast growing, small soft wooded tree, belongs to family papilonacea. Every part of SG is utilized for medicine in diuretic, emetic, fevers, headaches, smallpox, anemia, bronchitis, inflammation, leprosy, gout, rheumatism, anxiolytic, anticonvulsive, hepatoprotective and potent antidote for tobacco and smoking-related disease.10,11 Seeds of SG are possessing intellectual memory enhancer activity.12

MATERIALS AND METHODS

Animals

In the present study, all the experiment was carried out using aged male Swiss albino mice weighing between 30-35g were used. The animals were housed under standard conditions of temperature (24±2°C) and relative humidity (30-70%) with a 12:12h light-dark cycle. They were maintained on standard pellet chow diet (Ashirwaad Industries Private Ltd. Roped, India) and water ad libitum. The experimental protocol was approved by the Institutional Animal Ethical Committee (GLAIPR/CPCSEA/IAEC/2016/ R6) and the care of animals was taken as per the standard guidelines of CPCSEA.

Drug and Chemicals

Piracetam was purchased from UCB India Pvt. Ltd., India DTNB (5, 5 dithiobis 2-nitrobenzoate and acetyl thiocholine were purchased from Sigma Aldrich, Lt, Louis, MO, U.S.A., Celecoxib from Himedia Laboratories, Pvt. Ltd, Mumbai, India and thio-barbituric acid from Chemsworth, Pvt. Ltd, India. All the reagents used in the present study were of analytical grade.

Plant Materials

The dried fruits of Sesbania grandiflora were purchased from local market of Kanpur U.P., India and authenticated (specimen no. LWG-006) by the expert of botany from National Botanical Research Institute, Lucknow U.P., India.

Preparation of Extracts

The dried fruits of Sesbania grandiflora were grinded in the mixer and powder was pass through sieve number twelve and packed in air tight container for further use. The powder was packed into soxhlet column and succively extracted with petroleum ether (60-80°C), chloroform (50-60°C) and ethanol (78-90°C). The extracts were concentrated under reduced pressure and subjected for phytochemical analysis as per the previously described procedure;13 dried extracts were packed in air tight container and kept in refrigerator for further study.

Acute Toxicity Studies

Acute toxicity studies of ethanolic extract of SG (ESG) was performed as per the OECD guidelines 425. The limit test was done using a limit dose of 2000 mg/kg. at a dose of 50-2000 g/kg. Moreover, the experimental animals did not show any sign gross behavioral, neurological or auto-nomic toxic effect were observed after 3h administration of ESG and no any lethality were observed from 24h to 14 days.

Drug administration

Healthy swiss albino mice were divided in to 5 groups and each group having 6 animals. Group I served as positive control group and group II served as Disease control group or celecoxib treated group and treated with celecoxib 100 mg/kg p.o. for 9 days. Group III and IV served as drug treated group and pretreated for 14 days with ESG 200 and 400 mg/ kg p.o. doses respectively then treated with celecoxib same as II group. Group Vth served as standard drug treated group and treated with Piracetam 200 mg/kg i.p. after 30 min of celecoxib 100 mg/kg p.o. administration.14,15

Morris’s Water Maze

For the determination of the effect of ESG on memory of experimental animals, Morris water maze was used. It is one of the most commonly used animal models to test memory. The test was conducted according to the procedure and the parameters described by morris1984. The scored parameter escape latency time (ELT) and time spent in target quadrant (TSTQ) were recorded with the help of ANY Maze software.1620

Dissection and Homogenization

After behavioral assessments, the animals were sacrifice by cervical dislocation. The brains were removed and each brain was separately placed in ice and rinsed with ice cold isotonic saline. A (10% w/v) brain tissue homogenate was prepared in 0.1 M phosphate buffer (7.4 pH). The homogenate was centrifuged at 3000 rpm for 15 min at 4°C and aliquots of supernatant were separated and used for biochemical estimation.21

Acetylcholine Esterase Activity

AchE inhibitory activity of ESG was measured by method of Ellman et al., 1916.22 The homogenates were centrifuged at 1000 rpm for 10 min at 4°C and supernatant was used as a source of enzyme in AchE assay. For this 25μ of acetyl thiocholine iodide, 75μ of dithiobisnitrobenzoic acid (DTNB) and 75μ of tris HCl were added in test tube and incubated for 5 min at 25°C. Then the absorbance was measured at 405nm using a spectrophotometer. The enzyme activity was expressed as the “n” moles of substrate hydrolyzed/min/mg of protein.

Thiobarbituric Acid Reactive Substance (TBARS) Assay

For this 0.5 mL of Tris hydrochloric acid was added in 0.5 mL of supernatant and incubated at 37°C for 2h. After incubation 1 mL of 10% trichloro acetic acid was included and centrifuged at 3000 rpm for 10 min, and afterward 1mLof 0.67% thiobarbituric acid was added to 1 mL of supernatant. The tubes were kept in boiling water for 10 min and then cooled at room temperature. After cooling 1 mL of distilled water was added and absorbance was measured at 532 nm.23

Catalase Activity

Catalase activity was assessed by the method of Luck (1971). In this the breakdown of hydrogen peroxide is measured. Three mL of H2O2 phosphate buffer was added in 0.05 mL of supernatant of the tissue homogenate and absorbance was recorded at 240 nm using Lab India spectrophotometer. The results were expressed as micromoles of H2O2 decomposed per min per mg of protein.24

Estimation of Brain GSH

The GSH content in brain was estimated spectrophotometrically at 412 nm using the method of Beutler et al., Briefly, the supernatant of homogenate was mixed with trichloro acetic acid (10% w/v) in 1:1 ratio. The mixture was centrifuged at 1000 rpm for 10 min at 40C. The supernatant obtained (0.5mL) was mixed with 2 mL of 0.3 M disodium hydrogen phosphate, then 0.25 mL of 0.001 M freshly prepared DTNB was added and absorbance was noted by using spectrophotometer at 412 nm.25

Speroxide Dismutase

SOD activity was assessed by the method of Kakkar et al. 0.1 mL of 186 μM phenazinemethosulpahte and 1.2 mL of 0.052 mM sodium pyrophosphate buffer (pH 7.0) and 0.3 mL of supernatant of tissue homogenate was added. To start enzyme reaction 0.2 mL of 780 μM NADH was added as a catalyst in reaction mixture and incubated for one min. After incubation 1 mL of glacial acetic acid was added to stop the enzyme reaction.26

Statistical Analysis

All the values of the experimental results were expressed as mean ± standard error of mean (SEM). One-way ANOVA followed by Bert lets multiple comparison tests repeated measure were applied for the statistical analysis of all the parameters. Graph Pad Prism (version 5.03) software was used for all statistical analysis and p< 0.05 was considered as significant.

RESULTS

Acute toxicity studies and phytochemical analysis:

Administration of ESG up to the dose of 2000 mg/kg b.w in mice did not show any harmful effect on peripheral and central nervous system up to the 14 days of observation. Phytochemical screening of the different extracts of SG showed the presence of carbohydrate steroids, glycoside, flavonoid, tannin, saponin and phenolic compounds Table 1.

The result of the Morris’s water maze shows that the treatment of Celecoxib (100 mg/kg p.o.) significantly p<0.05 increase the escape latency time when compared to normal control group. However, the treatment of Piracetam (200 mg/kg) and ESG 200 and 400 mg/kg significantly decrease the escape latency time when compare to disease control group. As shown in Figure 3 that there was significant reduction p <0.001 was observed in time spent in target quadrant by the celecoxib treated mice. However, the treatment of piracetam 200 mg/kg and ESG 400 mg/ show significant p<0.05 increment in time spent in target quadrant when compared with normal control group. Figure 1,2,3.

Table 1:

Result of Phytocchemical analysis of various extracts of Sesbania grandiflora.

S.No.Plant constituentPet. ether extractChloroform extractEthanol extract
1Carbohydrates+--+
2Alkaloids--++
3Steroids+++
4Tannin and polyphenols--++
5Flavonoid--++
6Amino acids----+
7Saponins+--+
8Proteins----+
9Glycosides----+

+= Presence -= Absent

Morris’s water maze

Figure 1:

Effect of ESG and Piracetam on escape latency time on 1st day. n=6 Results are expressed as mean ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g001.jpg
Figure 2:

Effect of ESG and Piracetam on escape latency time on 4th day. (n=6) Results are expressed as mean ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05 vs disease control group and #P<0.05 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g002.jpg
Figure 3:

Effect of ESG and Piracetam on TSTQ. (n=6) Results are expressed as mean ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05, **P<0.001 vs disease control group and #P<0.001 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g003.jpg
Figure 4:

Effect of ESG and Piracetam on AchE activity. (n=6) Results are expressed as mean of AchE concentration ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05, **P<0.001 vs disease control group and #P<0.001 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g004.jpg

Estimation of Biochemical Parameters

Acetylcholine Esterase Activity

After performing the behavioral parameter, the AchE activity was measured by the method of Ellman et al. There was significant p<0.05 increase in brain AchE level was found in the Celecoxib treated animals when compared with normal control group. Piracetam and ESG treatment significantly p<0.05 inhibited the brain AchE level compared to their corresponding celecoxib group. Figure 4.

Thiobarbituric Acid Reactive Substance (TBARS) Assay

A significant increment (p <0.05) in the brain malondialdehyde level was observed in Celecoxib treated mice was found when compared to the normal control group Figure 5. Treatment of ESG and piracetam significantly (p <0.05) decrease the brain MDA level compared to their corresponding celecoxib group.

Figure 5:

Effect of ESG and Piracetam MDA level (n=6) Results are expressed as mean of MDA level ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05, **P<0.001 vs disease control group and #P<0.001 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g005.jpg
Figure 6:

Effect of ESG and Piracetam on GSH level. (n=6) Results are expressed as mean of GSH concentration ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05, **P<0.001 vs disease control group and #P<0.001 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g006.jpg
Figure 7:

Effect of ESG and Piracetam on H2O2 scavenging activity. (n=6) Results are expressed as mean percentage of H2O2 scavenging level ± SEM. Data was analyzed by One-way ANOVA followed by Bertlet’s test *P<0.05, **P<0.001 vs disease control group and #P<0.001 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g007.jpg
Figure 8:

Effect of ESG and Piracetam on Superoxide Dismutase (SOD) (n=6) Results are expressed as mean ± SEM. Data was analyzed by One way ANOVA followed by Bertlet’s test *P<0.05 vs disease control group and #P<0.05 vs normal control group.

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g008.jpg

Antioxidant activity

There was significant decrease in the SOD, GSH and catalyase activity was found when compared to normal control group. Treatment of piracetam significantly restores the level of GSH, SOD and catalayse activity in experiment animals when compared with disease control group. ESG 400 mg/kg significantly (p <0.001) prevented the decrement in level of above enzyme Figure 6,7,8 when compared to disease and piracetam treated animals. However, pretreatment of ESG 200 mg/kg could not significantly increase the level of GSH, SOD and catalayse when compared to piracetam treated animals.

DISCUSSION

Plant extracts having numerous dynamic compounds which are responsible for its widespread therapeutic activities and minimal side effects in compare to synthetic molecules.27 Phytochemical screening of the different extracts of Sesbania grandiflora revealed the presence of saponin glycosides, flavonoid, tannin and phenolic compounds. In the present study ethanolic extracts have been chosen due to its expected flavonoid content and good relationship between phenolics and antioxidant activity shown by the researchers.28

In the current study Morris’s water maze was used as a behavioral model to evaluate the impact of extract on memory. In this model decline in escape latency time and expansion in time spent in target quadrant demonstrate a change in memory and learning.29 Mice treated with celecoxib demonstrated more delayed escape latency time than mice from the normal control group. Pretreatment of ESG and piracetam for nine days significantly (p<0.001) mitigated the celecoxib induced amnesia in mice as indicated by decrease the escape latency time and increase in time spent in target quadrant (TSTQ) in Morris’s water maze test.

In addition to impairment of learning and memory function there is also enhancement of brain AchE activity occurs in celecoxib (100 mg/kg for 9 days; 5days persistent and 4 back to back days) treated mice. A number of studies have reported that the cholinergic system play a important role in learning and memory.30 The brain acetylcholine level determines the memory functions and AchE are responsible for deactivating brain Ach.31,32 It is an enzyme of carboxylesterase family that catalyzes the breakdown of ACh and of some other choline esters that act as neurotransmitters.33 The data of the current study revealed that the AchE activity was decreased in ESG treated mice, this decrement was nearly equally significant (P<0.05) to the Piracetam group. Thus, it can be said that the ant amnesic effect of ESG might be due to changes in cholinergic system.

Further this investigation additionally assessed whether such impairment in memory function by celecoxib is related with changes in oxidative marker. Reactive oxidative species (ROS) are produced ceaselessly in nervous system. The neurons are especially sensitive for oxidative damage and have high oxygen utilization, as compare to other organs.34 MDA is most willingly used assay for the product of lipid peroxidation.35 Treatment of ESG significantly attenuated the elevated level of MDA in celecoxib treated animals. Glutathione is an endogenous antioxidant presenting in the reduced form within the all mammalian cells36 and react with free radicals and prevent generation of hydroxyl free radicals.37 The diminished level of GSH activity in Celecoxib-treated animals shows that there is an increased generation of free radicals and decreased activity of glutathione system in battling oxidative stress. Administration of ESG restores the level of catalase, SOD and GSH in celecoxib treated rats. So, it can be said that the ESG have neuroprotective activity in experimental animals and this protective effect could be due to the presence of phytochemicals such as flavonoids and phenolic compounds, which modify the release of acetylcholine synthesis or inhibit the acetylcho-lineesterase enzyme38,39 or potentiate the synthesis of antioxidant enzyme which is beneficial for neuronal injury.40

CONCLUSION

The present study has shown that the significant neuroprotective effect at the doses of 200 and 400 mg/kg in mice. This could be due to the presence of wide range of phytochemical which fight against the free radicals.

GRAPHICAL ABSTRACT

https://s3-us-west-2.amazonaws.com/jourdata/pj/PharmacognJ-10-4-747-g009.jpg

REFERENCES

1. 

Mansa S, Raju AB, authors. Anti-amnesic activity of Solanum melongena L extract. Postepy fftoterpii. 2014;1:1–7

2. 

Vijayalakshmi, Adiga S, Bhat P, Chaturvedi A, Bairy KL, Kamth S, authors. Evaluation of the effect of Ferula asafetida Linn. Gum extract on learning and memory in wistar rats. I J Pharmacology. 2011;44(1):82–7. https://doi.org/10.4103/0253-7613.91873; PMID:22345876.

4. 

Louise R, Eugene T, John PT, authors. Dementia: timely diagnosis and early intervention. BMJ. 2015;300:h3029https://doiorg/101136/bmjh3029.

5. 

Konstantina GY, Sokratis GP, authors. Current and futue treatment for alzhemier disease. Thera Adv Neurological Disorders. 2013;6(1):19–33. https://dx.doi.org/10.1177%2F1756285612461679.

6. 

Cummings JL, author. Alzhemiers disease. New England J Med. 2004;351:56–7. https://doi.

7. 

Sariva ME, Ulisees AVR, Ribeiro DA, Oliveira LGS, Macedo DG, Sousa FFD, authors. Plant species as a therapeutic resource in areas of the savanna in the state of Pernambuco, Northeast Brazil. J ethnopharmacology. 2015;171:141–53. https://doiorg/101016/jjep201505034.

8. 

Joshi H, Parle M, authors. Zingiber officinale: Evaluation of its Nootropic effect in mice. African J Trad Complementary Alter Med. 2006;3(1):64–74

9. 

Burkar BB, Dayom DW, Uguru MO, authors. The Growing Economic Importance of Medicinal Plants and The Need for Developing Countries to Harness From it: A Mini Review. IOSR J Phar. 2016;6(5):42–2

10. 

Patil RB, Nanjwade BK, Manvi FV, authors. Effect of Sesbania grandiflora and Sesbania sesban bark on carrageenan induced acute inflammation and adjuvant-induced arthritis in rats. Inter J Pharmacologic Sci. 2010;1(1):75–100

11. 

Nadkarni AK, Nadkarni KM, authors. Indian material medica, Bombay Popular prakashan. 11999;

12. 

Kasture VS, Deshmukh VK, Chopde CT, authors. Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytotherapy Res. 2002;16(5):455–60. https://doi.org/10.1002/ptr.971.

13. 

Khandelwal KR., author. Practical Pharmacognosy, Nirali prakashan. 2001;

14. 

Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, et al., authors. Diverse compounds mimic Alzheimer’s disease-causing mutations by augmenting production. Nat Med. 2005;11(5):545–50. https://doi.org/10.1038/nm1235.

15. 

Tathe PR, Bheemachari V, Uplanchiwar A, Modi R, Gahane SK, Jain R, authors. Hepato- protective Activity of Fruit Extract of Sesbania grandiflora, (Pers). Pharmacology. 2010;3:423–30

16. 

Morris R, author. Developments of a water maze procedure for studying spatial learning in the rat. J Neuroscience Methods. 1984;11(1):47–60

17. 

Parle M, Singh N, authors. Animal models of testing memory. Asia pacific J Pharmacology. 2004;16:101–20

18. 

Sharma B, Puri M, Tiwary AK, Singh N, Jaggi AS, authors. Anti-amnesic effect of stevioside in scopolamine-treated rats. I J Pharmacology. 2010;42(3):164–7. DOI: 10.4103/0253-7613.66840

19. 

Sharma B, Singh N, Singh M, authors. Modulation of celecoxib and streptozotocin induced experimental dementia of Alzheimer’s disease type by pitavastatin and donepezil. J Psychopharmacology. 2008;22(2):162–71. https://doi.org/10.1177/0269881107081553.

20. 

Sharma B, Singh N, authors. Experimental hypertension induced vascular dementia: Pharmacological, biochemical and behavioral recuperation by angiotensin receptor blocker and acetylcholinesterase inhibitor. Pharmacology Biochemistry Behavior. 2012;102(1):101–8. https://doi.org/10.1016/j.pbb.2012.03.029.

21. 

Goverdhan P, Sravanthi A, Mamatha T, authors. Neuroprotective effects of Meloxicam and Selegiline in scopolamine-induced cognitive impairment and oxidative stress. Inter J Alzheimer’s Dis. 2012;(2012): Article ID 974013. DOI: 101155/2012/974013

22. 

Ellman GL, Courtney DK, Andres V, Feathstone RM, authors. A new and rapid colorime- teric determination of acetylcholinesterase activity. Biochemistry Pharmacology. 1961;7:88–95. https://doi.org/10.1016/0006-2952(61)90145-9.

23. 

Talpate KA, Bhosale UA, Zambare MR, Somani RS, authors. Neuroprotective and nootropic activity of Clitorea ternatea Linn. (Fabaceae) leaves on diabetes induced cognitive decline in experimental animals. J Pharm Bioallied Sci. 2014;6(1):48–55. DOI: 10.4103/0975-7406.124317. PMCID: PMC3895294.

24. 

Kumar A, Naidu PS, Sehgal N, Padi SSV, authors. Effect of curcumin on intracerebro- ventricular colchicine-induced cognitive impairment and oxidative stress in rats. J Med Food. 2007;10(3):486–94. https://doi.org/10.1089/jmf.2006.076.

25. 

Shamnas M, Ratendra R, Teotia UVS, authors. Neuroprotective activity of methanol extract of Salvia officinalis flowers in dementia related to Alzheimer disease. Der pharma sinica. 2014;5(2):29–38

26. 

Kakkar P, Das B, Viswanathan PN, authors. A modified spectrophotometric assay of superoxide dismutase. Indi J Biochemistry Biophysics. 1984;21:130–2

27. 

Mouhseen L, author. The success of natural product in drug discovery. Pharmacology and Pharmacy. 2013;4(3A):17–31. http://dxdoiorg/104236/pp201343A003.

28. 

Imran M, Khan H, Shah M, Khan R, Khan F, authors. Chemical composition and antioxidant activity of certain Morus species. J Zhejiang Univ Sci B. 2010;11(12):973–80. https://doiorg/101631/jzusB1000173, PMID: 21121077.

29. 

Dhingra D, Kumar V, authors. Memory enhancing activity of palmatine in mice using elevated plus maze and Morris water maze Advances in pharmacological sciences. 2012;2012: http://dx.doi.org/10.1155/2012/357368 Paper ID 357368.

30. 

Ismail OI, Tota SK, Adeyemi OO, Agbaje EO, Shukla R, authors. Protective effect of cnestis ferruginea and its active constituents on scopolamine induced memory impairment in mice: a behavioral and biochemical study. J Pharmaceutical Bio. 2013;51(7):825–35. http://dxdoiorg/103109/138802092013767360.

31. 

Sobharani R, Pal AK, Bhattacharjee A, Mitra S, Aguan K, authors. Screening Indigenous medicinal Plants of Northeast India for their anti - Alzhemier Properties. Pharmacognosy J. 2017;9(1):46–54

32. 

Joshi H, Kaur N, Chauhan J, authors. Evaluation of Nootropic effect of Argyreia speciosa in mice. J Health. 2007;53(4):382–8. hhttps://doiorg/101248/jhs53382.

33. 

Qi B, Zhang L, Zhang Z, Ouyang J, Huang H, authors. Effects of ginsenosides-Rb 1 on exercise-induced oxidative stress in forced swimming mice. Pharmacognosy Mag [serial online]. 2014;[cited 2017 Jul 31]. 10(40):458–63. Available from: http://wwwphcogcom/textasp72014/10/40/458/141818.

34. 

Colovic MB, Krstic DZ, Pasti TDL, Bondzic AM, Vasic VM, authors. Acetylcholine esterase inhibitor: Pharmacology and toxicology. Current Neuropharmacology. 2013;11(3):315–35. https://dx.doi.org/10.2174%2F1570159X11311030006 PMCID: PMC3648782.

35. 

Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC, authors. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur J Pharmacology. 2008;588(1):78–84. https://doi. org/10.1016/j.ejphar.2008.04.015 PMID:18462717.

36. 

Shrivastava S, Uthra C, Rashil MS, Shukla S, authors. Protective Role of Kaempferol Against Acrylamide Intoxication. Free Radicals Antioxidants. 2017;7(1):36–42

37. 

Lobo V, Patil A, Phatak A, Chandra N, authors. Free Radical, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews. 2010;4(8):118–26. https://dx.doi.org/10.4103%2F0973-7847.70902 PMCID: PMC3249911.

38. 

Zhu SY, Dong Y, Tu J, Zhou Y, Zhou XH, Xu B, authors. Silybum marianum oil attenuates oxidative stress and ameliorates mitochondrial dysfunction in mice treated with D-galactose. Pharmacognosy Mag. 2014;

39. 

Orhan I, Sener B, authors. Acetylcholinesterase inhibitors from natural resources. FABAD J Pharm Sci. 2003;

40. 

Ahmed F, Narendra SCJN, Manjunath S, authors. Acetylcholine and memory-enhancing activity of Ficus racemosa bark. Pharmacognosy Res [serial online]. 2011;[cited 2017 Jul 31];. 3(4):246–9. Available from: http://www.phcogres.com/textasp?2011/3/4/246/89744.

41. 

David V, Katerina V, Ana RM, Catarina R, Jeremy PES, authors. The Neuroprotective potential of flavonoid: a multiplicity of effects. Genes Nutr. 2008;3(3-4):115–26. https://dx.doi.org/10.1007%2Fs12263-008-0091-4 PMCID: PMC2593006.